Global Addictions Therapeutics Market Outlook 2024, Forecast To 2033
8 Mar, 2024
The addictions therapeutics market has also seen strong growth, rising from $6.56 billion in 2023 to $7.01 billion in 2024, with a CAGR of 6.8%. This growth is driven by factors such as increased substance abuse and rising awareness of addiction treatment initiatives. Looking ahead, the market is expected to see continued growth, reaching $8.83 billion in 2028, with a CAGR of 6.0%. Factors such as rising drug awareness campaigns and the emergence of synthetic drugs will contribute to this growth.
Global Addictions Therapeutics Market Key Driver
Increasing consumption of alcohol is anticipated to drive the growth of the addiction therapeutics market. According to a report by Statistics Canada, alcoholic beverage sales totaled $26.1 billion in the fiscal year ending on March 31, 2022, with wine sales seeing a 2.1% increase and beer constituting 34.9% of the total alcohol sales value in 2021–2022. This underscores the demand for addiction therapeutics to address alcohol-related issues such as withdrawal symptoms and cravings.
Get A Free Sample Of The Global Addictions Therapeutics Market ReportGlobal Addictions Therapeutics Market Segments
The addictions therapeutics market covered in this report is segmented –
1) Drug Type:Buprenorphine, Naltrexone, Bupropion, Disulfiram, Nicotine Replacement Products, Varenicline, Other Drugs
2) Treatment Type:Opioid Addiction Treatment, Alcohol Addiction Treatment, Nicotine Addiction Treatment, Other Substance Addiction Treatment
3) Treatment Center:Inpatient Treatment Center, Residential Treatment Center, Outpatient Treatment Center
4) Distribution Channel:Hospital Pharmacies, Medical Stores, Other Distribution Channel
5) Application:Public, Private, Government
By Geography: The countries covered in the addictions therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
North America was the largest region in the addictions therapeutics market in 2023. The regions covered in the addictions therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Major Addictions Therapeutics Industry Players
Pfizer Inc.; Novartis AG; GlaxoSmithKline plc; Gilead Sciences Inc.; Novo Nordisk A/S; Teva Pharmaceutical Industries Ltd.; Mylan N.V.; Bausch Health Companies Inc.; Sun Pharmaceutical Industries Limited; Perrigo Company plc; Purdue Pharma L.P.; Dr. Reddy's Laboratories Ltd.; Cipla Inc.; Hikma Pharmaceuticals plc; Amneal Pharmaceuticals Inc.; Mallinckrodt Plc; Alkermes plc.; Glenmark Pharmaceuticals Limited; Indivior plc.; Lannett Company Inc.; BioDelivery Sciences International Inc.; Insys Therapeutics Inc.; Camurus AB; Orexo AB; Elite Pharmaceuticals Inc.; Alchem International Ltd; Avalo Therapeutics Inc.; Braeburn Inc.; Titan Pharmaceuticals Inc.; BioCorRx Inc.
Get The Full Global Addictions Therapeutics Market Report
Addictions Therapeutics Market Overview
Addiction therapeutics refers to medication, treatment, and management of various forms of addiction to help individuals overcome substance use disorders (SUDs) and other forms of addiction. It involves group and individual therapy sessions to prevent substance misuse.